BOSTON — Vertex Pharmaceuticals reshaped the way doctors treat cystic fibrosis, turning what was once a childhood death sentence into a manageable condition — and making the Boston biotech a multibillion-dollar company in the process.
Its next goal? Reproducing that success.
Create a display name to comment
This name will appear with your comment